Clinical Trial Update: Evaluation of the Efficacy and Safety of Clazosentan in Reversing Cerebral Vasospasm in Adult Subjects With Aneurysmal Subarachnoid Hemorrhage [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of clazosentan for reversing cerebral vasospasm in adults with aneurysmal subarachnoid hemorrhage; the study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aneurysmal Subarachnoid Hemorrhage

Drugs mentioned

• Clazosentan (clazosentan)

Snippet

Sponsor: Idorsia Pharmaceuticals Ltd. | Conditions: Aneurysmal Subarachnoid Hemorrhage | Phase 2 | Status: COMPLETED